USFDA updates safety warnings for opioid treatment drugsĀ
HQ Team April 14, 2023: New safety warnings will be required on prescription labels for opioid pain relievers to prevent addiction and overdose,.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team April 14, 2023: New safety warnings will be required on prescription labels for opioid pain relievers to prevent addiction and overdose,.
US-based Emergent BioSolutions announced that FDA had approved its nasal spray Narcan as an over-the-counter emergency treatment for opioid overuse.
October 22, 2022: Walmart has agreed to pay Florida $215 million to settle claims that its pharmacies aided an opioid crisis in the.